Tambagel, Rhea Mae .
HRN: 22-48-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2025
CEFUROXIME 750MG (VIAL)
01/04/2025
01/11/2025
IV
750mg
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractBloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes